Incidence, Mortality, and Trends of Prostate Cancer in Mexico from 2000 to 2019: Results from the Global Burden of Disease Study 2019

Abstract

In 2019, the Global Burden of Disease (GBD) estimated that prostate cancer (PC) was the 16th most common cause of death globally in males. In Mexico, PC epidemiology has been studied by a number of metrics and over various periods, although without including the most up-to-date estimates. Herein, we describe and compare the burdens and trends of PC in Mexico and its 32 states from 2000 to 2019. For this study, we extracted online available data from the GBD 2019 to estimate the crude and age-standardized rates (ASR per 100,000 people) of the incidence and mortality of PC. In Mexico, PC caused 27.1 thousand (95% uncertainty intervals, 20.6–36.0 thousand) incident cases and 9.2 thousand (7.7–12.7 thousand) deaths in males of all ages in 2019. Among the states, Sinaloa had the greatest ASR of incidence, and Guerrero had the highest mortality. The burden of PC showed an increasing trend, although the magnitude of change differed between metrics and locations. We found both an increasing national trend and subnational variation in the burden of PC. Our results confirm the need for updated and timely estimates to design effective diagnostic and treatment campaigns in locations where the burden of PC is the highest.

Immunotherapy in prostate cancer: fundamentals and opportunities for its application in the clinic

“…Prostate cancer (PC) is one of the main cancers in men and is ranked second in terms of incidence (1.4 million new cases), with this malignancy being the most prevalent in the world (3,724,658 cases). This panorama is very similar for our country (27,096 new cases) [1][2][3] .…”

Anticancer Properties of Mexican Medicinal Plants: An Updated Review

“…76 Among men, various types of cancer have exhibited the highest mortality rates; some of these subtypes include lung, gastric, and prostate cancer. 77 In contrast, cervical and breast cancer are the most frequently diagnosed among women younger than 50 years old. 76,78 Given the limitations of current treatment modalities against cancer, traditional medicine and its derivatives (eg, aromatherapy and acupuncture) are considered an alternative to disrupt key carcinogenic phenomena such as angiogenesis, metastasis, and proliferation.…”

“…76 Among men, various types of cancer have exhibited the highest mortality rates; some of these subtypes include lung, gastric, and prostate cancer. 77 In contrast, cervical and breast cancer are the most frequently diagnosed among women younger than 50 years old. 76,78…”

Inmunoterapia en cáncer de próstata: fundamentos y oportunidades para su aplicación en la clínica

“…El cáncer de próstata (CP) constituye uno de los principales cánceres en hombres y representa el segundo lugar en incidencia (1.4 millones nuevos casos), siendo el de mayor prevalencia en el mundo (3,724,658 casos). Este panorama es muy similar para nuestro país (27,096 nuevos casos) [1][2][3] .…”